Astrocytoma, IDH-Mutant, Grade 2 — Trials

Astrocytoma, IDH-Mutant, Grade 2 — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07673666	GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3)(GliomaAI-A23)	completed	—	1,372	Deep Learning Institute of Radiological SciencesOTHER	1	Jun 29, 2026	clinicaltrials

Data updated 22 days agoSource updated Jun 29, 2026source: clinicaltrials